Team:DTU-Denmark/IP and Synthetic Biology
From 2013.igem.org
(Difference between revisions)
Helencook (Talk | contribs)
(Created page with "{{:Team:DTU-Denmark/Templates/StartPage|Discussion on IP and Synthetic Biology}} In order to discuss the issues around intellectual property rights and synthetic biology, we met...")
Newer edit →
(Created page with "{{:Team:DTU-Denmark/Templates/StartPage|Discussion on IP and Synthetic Biology}} In order to discuss the issues around intellectual property rights and synthetic biology, we met...")
Newer edit →
Revision as of 17:36, 12 September 2013
Discussion on IP and Synthetic Biology
In order to discuss the issues around intellectual property rights and synthetic biology, we met with:
- Jakob Krag Nielsen, IP lawyer at Rønne & Lundgren
- Michael Cohen, IP lawyer at Gray Plant Moody
- Thomas Tscherning, director at TTO of Aarhus University
Our discussion focused around the impact that the recent Myriad Genetics Supreme Court ruling would have on synthetic biology.